Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $54,214 | $175,949 | $119,188 | $71,878 |
| - Cash | $212,071 | $12,097 | $20,865 | $54,525 |
| + Debt | $3,810,166 | $4,477,884 | $4,910,517 | $5,036,526 |
| Enterprise Value | $3,652,309 | $4,641,736 | $5,008,840 | $5,053,879 |
| Revenue | $3,906,223 | $4,565,834 | $4,976,650 | $5,373,740 |
| % Growth | -14.4% | -8.3% | -7.4% | – |
| Gross Profit | $1,650,023 | $2,080,824 | $2,189,742 | $2,336,872 |
| % Margin | 42.2% | 45.6% | 44% | 43.5% |
| EBITDA | $136,295 | $312,779 | $309,794 | -$214,431 |
| % Margin | 3.5% | 6.9% | 6.2% | -4% |
| Net Income | -$58,963 | $14,619 | -$235,231 | -$578,982 |
| % Margin | -1.5% | 0.3% | -4.7% | -10.8% |
| EPS Diluted | -0.53 | 0.1 | -2.33 | -6.15 |
| % Growth | -630% | 104.3% | 62.1% | – |
| Operating Cash Flow | $315,731 | -$7,166 | $18,584 | $120,455 |
| Capital Expenditures | -$55,616 | -$62,727 | -$51,152 | -$64,106 |
| Free Cash Flow | $260,115 | -$69,893 | -$32,568 | $56,349 |